127 related articles for article (PubMed ID: 36800243)
1. Increased 18 F-Fluoroestradiol Uptake of Radiation Pneumonitis in a Patient With Metastatic Breast Cancer.
Pan B; Hao Z; Zhou Y; Sun Q; Huo L
Clin Nucl Med; 2023 May; 48(5):437-438. PubMed ID: 36800243
[TBL] [Abstract][Full Text] [Related]
2. Diffuse bilateral
Phillips EF; Karak PK
J Med Imaging Radiat Sci; 2023 Dec; 54(4):726-731. PubMed ID: 37620179
[TBL] [Abstract][Full Text] [Related]
3. Increased (18)F-fluoroestradiol uptake in radiation pneumonia.
Yang Z; Sun Y; Yao Z; Xue J; Zhang Y; Zhang Y
Ann Nucl Med; 2013 Dec; 27(10):931-4. PubMed ID: 23949891
[TBL] [Abstract][Full Text] [Related]
4. Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?
Yang Z; Sun Y; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
Clin Breast Cancer; 2013 Oct; 13(5):359-63. PubMed ID: 23787040
[TBL] [Abstract][Full Text] [Related]
5. 18 F-FES Uptake in Radiation Pneumonitis.
Mahalik A; Chaudhary B; Kumar R; Tripathi M; Bal C
Clin Nucl Med; 2023 Oct; 48(10):e468-e469. PubMed ID: 37566798
[TBL] [Abstract][Full Text] [Related]
6. The Predictive Value of Early Changes in
He M; Liu C; Shi Q; Sun Y; Zhang Y; Xu X; Yuan H; Zhang Y; Liu Y; Liu G; Di G; Yang Z; Wang Z; Shao Z
Oncologist; 2020 Nov; 25(11):927-936. PubMed ID: 32272493
[TBL] [Abstract][Full Text] [Related]
7. Long-term Trace of Radiation Pneumonitis With 18F-Fluoroestradiol.
Morel A; Maucherat B; Chiavassa S; Kraeber-Bodéré F; Rousseau C
Clin Nucl Med; 2020 Sep; 45(9):e403-e405. PubMed ID: 32657871
[TBL] [Abstract][Full Text] [Related]
8.
Nienhuis HH; van Kruchten M; Elias SG; Glaudemans AWJM; de Vries EFJ; Bongaerts AHH; Schröder CP; de Vries EGE; Hospers GAP
J Nucl Med; 2018 Aug; 59(8):1212-1218. PubMed ID: 29602822
[TBL] [Abstract][Full Text] [Related]
9. Clinical Validity of 16α-[
van Geel JJL; Boers J; Elias SG; Glaudemans AWJM; de Vries EFJ; Hospers GAP; van Kruchten M; Kuip EJM; Jager A; Menke-van der Houven van Oordt WC; van der Vegt B; de Vries EGE; Schröder CP;
J Clin Oncol; 2022 Nov; 40(31):3642-3652. PubMed ID: 35584346
[TBL] [Abstract][Full Text] [Related]
10. The Assessment of Estrogen Receptor Status and Its Intratumoral Heterogeneity in Patients With Breast Cancer by Using 18F-Fluoroestradiol PET/CT.
Yang Z; Sun Y; Xu X; Zhang Y; Zhang J; Xue J; Wang M; Yuan H; Hu S; Shi W; Zhu B; Zhang Y
Clin Nucl Med; 2017 Jun; 42(6):421-427. PubMed ID: 28221191
[TBL] [Abstract][Full Text] [Related]
11. The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.
Sun Y; Yang Z; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
PLoS One; 2015; 10(1):e0116341. PubMed ID: 25617853
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy and safety of 16α-[
Chae SY; Ahn SH; Kim SB; Han S; Lee SH; Oh SJ; Lee SJ; Kim HJ; Ko BS; Lee JW; Son BH; Kim J; Ahn JH; Jung KH; Kim JE; Kim SY; Choi WJ; Shin HJ; Gong G; Lee HS; Lee JB; Moon DH
Lancet Oncol; 2019 Apr; 20(4):546-555. PubMed ID: 30846327
[TBL] [Abstract][Full Text] [Related]
13. Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.
Kurland BF; Wiggins JR; Coche A; Fontan C; Bouvet Y; Webner P; Divgi C; Linden HM
Oncologist; 2020 Oct; 25(10):835-844. PubMed ID: 32374053
[TBL] [Abstract][Full Text] [Related]
14. Head-to-Head Evaluation of
Ulaner GA; Jhaveri K; Chandarlapaty S; Hatzoglou V; Riedl CC; Lewis JS; Mauguen A
J Nucl Med; 2021 Mar; 62(3):326-331. PubMed ID: 32680923
[TBL] [Abstract][Full Text] [Related]
15. A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using
Jager A; de Vries EGE; der Houven van Oordt CWM; Neven P; Venema CM; Glaudemans AWJM; Wang Y; Bagley RG; Conlan MG; Aftimos P
Breast Cancer Res; 2020 Sep; 22(1):97. PubMed ID: 32912274
[TBL] [Abstract][Full Text] [Related]
16.
Peterson LM; Kurland BF; Yan F; Jiresova AN; Gadi VK; Specht JM; Gralow JR; Schubert EK; Link JM; Krohn KA; Eary JF; Mankoff DA; Linden HM
J Nucl Med; 2021 Feb; 62(2):184-190. PubMed ID: 32591490
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging for Estrogen Receptor-Positive Breast Cancer: Clinical Applications of Whole Body and Dedicated Breast Positron Emission Tomography.
Goodman K; Abel MK; Lawhn-Heath C; Molina-Vega J; Jones EF; Mukhtar RA
Surg Oncol Clin N Am; 2022 Oct; 31(4):569-579. PubMed ID: 36243494
[No Abstract] [Full Text] [Related]
18. Evaluation of tumour heterogeneity by
Liu C; Hu S; Xu X; Zhang Y; Wang B; Song S; Yang Z
Breast Cancer Res; 2022 Aug; 24(1):57. PubMed ID: 36028895
[TBL] [Abstract][Full Text] [Related]
19. To Identify Small Bowel Metastasis From Lobular Breast Cancer on 18 F-Fluoroestradiol PET/CT : Necessary to Adjust the Background Uptake Level.
Lu Y
Clin Nucl Med; 2023 Feb; 48(2):192-193. PubMed ID: 36083216
[TBL] [Abstract][Full Text] [Related]
20.
Wang Y; Ayres KL; Goldman DA; Dickler MN; Bardia A; Mayer IA; Winer E; Fredrickson J; Arteaga CL; Baselga J; Manning HC; Mahmood U; Ulaner GA
Clin Cancer Res; 2017 Jun; 23(12):3053-3060. PubMed ID: 28011460
[No Abstract] [Full Text] [Related]
[Next] [New Search]